Literature DB >> 9180666

The relation between antioxidants and memory performance in the old and very old.

W J Perrig1, P Perrig, H B Stähelin.   

Abstract

OBJECTIVES: Aging processes, and among them brain aging, are thought to be associated with free radical action. It is hypothesized that plasma antioxidant vitamin levels correlate with cognitive performance in healthy older subjects.
DESIGN: Longitudinal and cross-sectional comparisons.
SETTING: The city of Basle, considered representative of the older urban population in Switzerland. PARTICIPANTS: A total of 442 subjects aged 65 to 94 years (mean: 75 years; 312 male, 132 female) was selected from a random sample. MEASUREMENTS: In 1993, participants were tested for memory, and plasma vitamin levels were measured for the three antioxidants alpha-tocopherol, ascorbic acid, and beta-carotene. These vitamin parameters, measured previously in 1971 in the same sample, were integrated in our analyses. In addition, plasma cholesterol, ferritin, and systolic blood pressure were taken into account. Memory variables were priming, working-memory, free recall, recognition and the WAIS-R vocabulary test (semantic memory).
RESULTS: Correlations showed significant stability of the plasma antioxidants over the time lag of 22 years (alpha-tocopherol: r = .47, P < or = .001; beta-carotene: r = .43, P < .001; ascorbic acid: r = .22, P < .001). Free recall, recognition, and vocabulary (but not priming and working-memory) correlated significantly with ascorbic acid and beta-carotene in the cross-sectional 1993 data as well as in the longitudinal 1971-1993 analysis. These two antioxidants remained significant predictors, especially of semantic memory, after controlling for possible confounding variables like age, education, and gender using multiple regression analyses and ANOVAs.
CONCLUSION: Among people aged 65 and older, higher ascorbic acid and beta-carotene plasma level are associated with better memory performance. These results indicate the important role played by antioxidants in brain aging and may have implications for prevention of progressive cognitive impairments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180666     DOI: 10.1111/j.1532-5415.1997.tb01476.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  61 in total

Review 1.  The burden of dementia. A medical and research perspective.

Authors:  P Antuono; J Beyer
Journal:  Theor Med Bioeth       Date:  1999-01

Review 2.  Vitamins and cognition: what is the evidence?

Authors:  David O Kennedy; Crystal F Haskell
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 3.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

4.  Centella asiatica modulates antioxidant and mitochondrial pathways and improves cognitive function in mice.

Authors:  Nora E Gray; Christopher J Harris; Joseph F Quinn; Amala Soumyanath
Journal:  J Ethnopharmacol       Date:  2016-01-16       Impact factor: 4.360

Review 5.  Clinical trials in mild cognitive impairment: lessons for the future.

Authors:  V Jelic; M Kivipelto; B Winblad
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

Review 6.  How should we measure nutrition-induced improvements in memory?

Authors:  David Benton; K Wolfgang Kallus; Jeroen A J Schmitt
Journal:  Eur J Nutr       Date:  2005-12       Impact factor: 5.614

Review 7.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics.

Authors:  S Melov; S R Doctrow; J A Schneider; J Haberson; M Patel; P E Coskun; K Huffman; D C Wallace; B Malfroy
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 9.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 10.  All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.

Authors:  Hyun-Pil Lee; Gemma Casadesus; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Mark A Smith; Katarzyna Gustaw-Rothenberg; Alan Lerner
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.